KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Other Accumulated Expenses: 2012-2024

Historic Other Accumulated Expenses for Astrana Health (ASTH) over the last 10 years, with FY2024 value amounting to $209.0 million.

  • Astrana Health's Other Accumulated Expenses rose 10836.73% to $334.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $334.0 million, marking a year-over-year increase of 10836.73%. This contributed to the annual value of $209.0 million for FY2024, which is 9599.18% up from last year.
  • As of FY2024, Astrana Health's Other Accumulated Expenses stood at $209.0 million, which was up 9599.18% from $106.7 million recorded in FY2023.
  • Astrana Health's 5-year Other Accumulated Expenses high stood at $209.0 million for FY2024, and its period low was $50.3 million during FY2020.
  • In the last 5 years, Astrana Health's Other Accumulated Expenses had a median value of $81.3 million in 2022 and averaged $100.6 million.
  • In the last 5 years, Astrana Health's Other Accumulated Expenses crashed by 1429.54% in 2020 and then skyrocketed by 9599.18% in 2024.
  • Astrana Health's Other Accumulated Expenses (Annual) stood at $50.3 million in 2020, then increased by 10.83% to $55.8 million in 2021, then soared by 45.66% to $81.3 million in 2022, then skyrocketed by 31.26% to $106.7 million in 2023, then surged by 95.99% to $209.0 million in 2024.
  • Its Other Accumulated Expenses stands at $209.0 million for FY2024, versus $106.7 million for FY2023 and $81.3 million for FY2022.